Tomoyuki Tatenuma

Yokohama City University, Yokohama City University Hospital

Papers

23

Total Citations

137

H-Index

7

About

Tomoyuki Tatenuma is a urological surgeon and clinical researcher whose work centers on robot-assisted minimally invasive surgery for urological cancers, particularly prostate cancer and renal cell carcinoma. Based primarily at Yokohama City University Hospital and affiliated with the MSUG94 multicenter collaborative group in Japan, Tatenuma has made significant contributions to understanding the oncological and surgical outcomes of robot-assisted radical prostatectomy (RARP) and robot-assisted partial nephrectomy (RAPN). His research has challenged established assumptions — notably demonstrating that pelvic lymph node dissection may not improve biochemical recurrence-free survival in RARP patients — while also advancing knowledge of prognostic factors such as lymphovascular invasion and positive surgical margin location. His work on urinary continence recovery and functional outcomes after prostatectomy has direct clinical relevance for patient counseling. In the kidney cancer space, he has investigated complex surgical scenarios including complete endophytic renal tumors and optimal vascular clamping strategies. Tatenuma has also contributed to patient-specific surgical simulation and navigation systems. With citations reaching into the double digits across multiple publications since 2021, his collaborative, data-driven approach is shaping modern robotic urology practice in Japan and beyond.

Research Focus

Key Achievements

7
H-Index
23
Papers
137
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Pelvic Lymphadenectomy May Not Improve Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy in Japan (The MSUG94 Group)
15 citations · 2022
📈 Most Prolific Year: 2024 (7 Papers)
🤝 Key Collaborators: 50
🏛 Institutions: Yokohama City University, Yokohama City University Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago